312 related articles for article (PubMed ID: 23334664)
1. Prophylactic and antinociceptive effects of coenzyme Q10 on diabetic neuropathic pain in a mouse model of type 1 diabetes.
Zhang YP; Eber A; Yuan Y; Yang Z; Rodriguez Y; Levitt RC; Takacs P; Candiotti KA
Anesthesiology; 2013 Apr; 118(4):945-54. PubMed ID: 23334664
[TBL] [Abstract][Full Text] [Related]
2. Diabetic neuropathic pain development in type 2 diabetic mouse model and the prophylactic and therapeutic effects of coenzyme Q10.
Zhang YP; Song CY; Yuan Y; Eber A; Rodriguez Y; Levitt RC; Takacs P; Yang Z; Goldberg R; Candiotti KA
Neurobiol Dis; 2013 Oct; 58():169-78. PubMed ID: 23684663
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive effects of fisetin against diabetic neuropathic pain in mice: Engagement of antioxidant mechanisms and spinal GABAA receptors.
Zhao X; Li XL; Liu X; Wang C; Zhou DS; Ma Q; Zhou WH; Hu ZY
Pharmacol Res; 2015 Dec; 102():286-97. PubMed ID: 26520392
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain.
Toth CC; Jedrzejewski NM; Ellis CL; Frey WH
Mol Pain; 2010 Mar; 6():16. PubMed ID: 20236533
[TBL] [Abstract][Full Text] [Related]
5. Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms.
Pabreja K; Dua K; Sharma S; Padi SS; Kulkarni SK
Eur J Pharmacol; 2011 Jul; 661(1-3):15-21. PubMed ID: 21536024
[TBL] [Abstract][Full Text] [Related]
6. The soy isoflavone genistein reverses oxidative and inflammatory state, neuropathic pain, neurotrophic and vasculature deficits in diabetes mouse model.
Valsecchi AE; Franchi S; Panerai AE; Rossi A; Sacerdote P; Colleoni M
Eur J Pharmacol; 2011 Jan; 650(2-3):694-702. PubMed ID: 21050844
[TBL] [Abstract][Full Text] [Related]
7. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.
Bordet T; Buisson B; Michaud M; Abitbol JL; Marchand F; Grist J; Andriambeloson E; Malcangio M; Pruss RM
J Pharmacol Exp Ther; 2008 Aug; 326(2):623-32. PubMed ID: 18492948
[TBL] [Abstract][Full Text] [Related]
8. Secoisolariciresinol diglycoside, a flaxseed lignan, exerts analgesic effects in a mouse model of type 1 diabetes: Engagement of antioxidant mechanism.
Hu P; Mei QY; Ma L; Cui WG; Zhou WH; Zhou DS; Zhao Q; Xu DY; Zhao X; Lu Q; Hu ZY
Eur J Pharmacol; 2015 Nov; 767():183-92. PubMed ID: 26494631
[TBL] [Abstract][Full Text] [Related]
9. Alpha-lipoic acid and coenzyme Q10 combination ameliorates experimental diabetic neuropathy by modulating oxidative stress and apoptosis.
Sadeghiyan Galeshkalami N; Abdollahi M; Najafi R; Baeeri M; Jamshidzade A; Falak R; Davoodzadeh Gholami M; Hassanzadeh G; Mokhtari T; Hassani S; Rahimifard M; Hosseini A
Life Sci; 2019 Jan; 216():101-110. PubMed ID: 30393023
[TBL] [Abstract][Full Text] [Related]
10. Lycopene attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain.
Kuhad A; Sharma S; Chopra K
Eur J Pain; 2008 Jul; 12(5):624-32. PubMed ID: 18055235
[TBL] [Abstract][Full Text] [Related]
11. Emblica officinalis corrects functional, biochemical and molecular deficits in experimental diabetic neuropathy by targeting the oxido-nitrosative stress mediated inflammatory cascade.
Tiwari V; Kuhad A; Chopra K
Phytother Res; 2011 Oct; 25(10):1527-36. PubMed ID: 21394805
[TBL] [Abstract][Full Text] [Related]
12. Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice.
Huynh K; Kiriazis H; Du XJ; Love JE; Gray SP; Jandeleit-Dahm KA; McMullen JR; Ritchie RH
Free Radic Biol Med; 2013 Jul; 60():307-17. PubMed ID: 23454064
[TBL] [Abstract][Full Text] [Related]
13. Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes model.
Shi TJ; Zhang MD; Zeberg H; Nilsson J; Grünler J; Liu SX; Xiang Q; Persson J; Fried KJ; Catrina SB; Watanabe M; Arhem P; Brismar K; Hökfelt TG
Proc Natl Acad Sci U S A; 2013 Jan; 110(2):690-5. PubMed ID: 23267110
[TBL] [Abstract][Full Text] [Related]
14. Effect of coenzyme Q10 on catalase activity and other antioxidant parameters in streptozotocin-induced diabetic rats.
Modi K; Santani DD; Goyal RK; Bhatt PA
Biol Trace Elem Res; 2006 Jan; 109(1):25-34. PubMed ID: 16388100
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress.
Comelli F; Bettoni I; Colleoni M; Giagnoni G; Costa B
Phytother Res; 2009 Dec; 23(12):1678-84. PubMed ID: 19441010
[TBL] [Abstract][Full Text] [Related]
16. Physical exercise induces excess hsp72 expression and delays the development of hyperalgesia and allodynia in painful diabetic neuropathy rats.
Chen YW; Hsieh PL; Chen YC; Hung CH; Cheng JT
Anesth Analg; 2013 Feb; 116(2):482-90. PubMed ID: 23302966
[TBL] [Abstract][Full Text] [Related]
17. Alterations of erythrocyte free radical defense system, heart tissue lipid peroxidation, and lipid concentration in streptozotocin-induced diabetic rats under coenzyme Q10 supplementation.
Al-Thakafy HS; Khoja SM; Al-Marzouki ZM; Zailaie MZ; Al-Marzouki KM
Saudi Med J; 2004 Dec; 25(12):1824-30. PubMed ID: 15711648
[TBL] [Abstract][Full Text] [Related]
18. Rimonabant, a cannabinoid CB1 receptor antagonist, attenuates mechanical allodynia and counteracts oxidative stress and nerve growth factor deficit in diabetic mice.
Comelli F; Bettoni I; Colombo A; Fumagalli P; Giagnoni G; Costa B
Eur J Pharmacol; 2010 Jul; 637(1-3):62-9. PubMed ID: 20399204
[TBL] [Abstract][Full Text] [Related]
19. Effect of Coenzyme Q10 on Oxidative Stress, Glycemic Control and Inflammation in Diabetic Neuropathy: A Double Blind Randomized Clinical Trial.
Akbari Fakhrabadi M; Zeinali Ghotrom A; Mozaffari-Khosravi H; Hadi Nodoushan H; Nadjarzadeh A
Int J Vitam Nutr Res; 2014; 84(5-6):252-60. PubMed ID: 26255546
[TBL] [Abstract][Full Text] [Related]
20. Systemic and spinal administration of etanercept, a tumor necrosis factor alpha inhibitor, blocks tactile allodynia in diabetic mice.
Dogrul A; Gul H; Yesilyurt O; Ulas UH; Yildiz O
Acta Diabetol; 2011 Jun; 48(2):135-42. PubMed ID: 21104419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
